São Paulo, Brazil – December 8th 2025 SteinCares, a leading specialty healthcare company in Latin America, today announced the addition of Monofer® (iron isomaltoside 1000) into its Brazilian portfolio, following the recent transfer of commercialization rights. With this milestone, SteinCares strengthens its presence in Brazil and expands access to innovative treatments
San Jose, Costa Rica – August 26, 2025 – In line with its purpose to create healthcare opportunities across Latin America, SteinCares today announced the opening of its new secondary packaging facility in Costa Rica. This strategic investment is a milestone for SteinCares’ regional consolidation and will support its expansion and
San Jose, Costa Rica, July 28, 2025. SteinCares, a leading specialty healthcare company in Latin America operating in over 30 countries, today announced its official entry into the Mexican market through a strategic joint venture with Laboratorios Carnot, a leading Mexican pharmaceutical company with more than 80 years of experience in
Guangzhou, China and San Jose, Costa Rica, June 2025 —Bio-Thera Solutions, Ltd., a commercial-stage biopharmaceutical company developing a pipeline of innovative therapies and biosimilars, and SteinCares, a leading specialty healthcare company in Latin America, today announced the signing of a new agreement to commercialize a proposed biosimilar of dupilumab across Latin
Mumbai, Costa Rica, May 26, 2025: Global Pharma major Lupin Limited (Lupin) today announced that it has entered into a license and supply agreement with SteinCares, a leading specialty healthcare company in Latin America, for commercialization of Lupin’s biosimilar ranibizumab across Latin America excluding Mexico and Argentina. Under the terms
San Jose, Costa Rica, May 2025. SteinCares, a leading specialty healthcare company in Latin America, and Pharmacosmos, a leading international company that specializes in iron treatments have announced the launch of Monofer®—an innovative intravenous iron replacement therapy for those with a deficiency of this mineral—to six new markets: Ecuador, Dominican Republic, Guatemala,
San José, Costa Rica, April 2025. SteinCares, a leading specialty healthcare company in Latin America, is expanding its long-standing partnership with Medac GmbH, a global pharmaceutical company based in Germany, to bring Metoject® to four new markets: the Dominican Republic, Panama, Costa Rica, and Guatemala. This expansion builds on Metoject®’s successful
San Jose, Costa Rica, February 2024 – SteinCares, a leading specialty healthcare company in Latin America with a solid footprint in more than 30 countries across the region, announces its official expansion into the Brazilian market, marking a key milestone in its regional growth strategy. Under the leadership of Julio Avella,
Suzhou, China, January 20, 2025 – CStone Pharmaceuticals (“CStone”, HKEX: 2616), an innovation-driven biopharmaceutical company focused on the research and development of anti-cancer therapies, today announced a strategic commercialization partnership with SteinCares, a leading pharmaceutical company with over 40 years of experience anda strong presence in Latin America. Under this agreement, SteinCares
San Jose, Costa Rica, January 2025-. SteinCares, a leading specialty healthcare company in Latin America, has announced a commercialization agreement with Molteni Farmaceutici, an Italian company specializing in pain management, to expand access to Oramorph®, a Molteni Farmaceutici proprierty pharma product novel morphine oral solution across the region. The companies will
